161 related articles for article (PubMed ID: 16608883)
21. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
Green BD; Gault VA; O'Harte FP; Flatt PR
Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
[TBL] [Abstract][Full Text] [Related]
22. [Ser2]- and [SerP2] incretin analogs: comparison of dipeptidyl peptidase IV resistance and biological activities in vitro and in vivo.
Hinke SA; Manhart S; Kühn-Wache K; Nian C; Demuth HU; Pederson RA; McIntosh CH
J Biol Chem; 2004 Feb; 279(6):3998-4006. PubMed ID: 14610075
[TBL] [Abstract][Full Text] [Related]
23. Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide.
Gault VA; Harriott P; Flatt PR; O'Harte FP
Biosci Rep; 2002; 22(5-6):523-8. PubMed ID: 12635849
[TBL] [Abstract][Full Text] [Related]
24. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
Jia X; Brown JC; Ma P; Pederson RA; McIntosh CH
Am J Physiol; 1995 Apr; 268(4 Pt 1):E645-51. PubMed ID: 7733263
[TBL] [Abstract][Full Text] [Related]
25. Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects.
Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Sakagami H; Kitsunai H; Takiyama Y; Abiko A; Makino Y; Kieffer TJ; Haneda M
Mol Metab; 2017 Feb; 6(2):226-231. PubMed ID: 28180064
[TBL] [Abstract][Full Text] [Related]
26. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.
Kieffer TJ; McIntosh CH; Pederson RA
Endocrinology; 1995 Aug; 136(8):3585-96. PubMed ID: 7628397
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor.
Graham GV; Conlon JM; Abdel-Wahab YH; Gault VA; Flatt PR
Peptides; 2018 Feb; 100():182-189. PubMed ID: 29157578
[TBL] [Abstract][Full Text] [Related]
28. Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo.
Gault VA; Parker JC; Harriott P; Flatt PR; O'Harte FP
J Endocrinol; 2002 Nov; 175(2):525-33. PubMed ID: 12429050
[TBL] [Abstract][Full Text] [Related]
29. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.
Wheeler MB; Gelling RW; McIntosh CH; Georgiou J; Brown JC; Pederson RA
Endocrinology; 1995 Oct; 136(10):4629-39. PubMed ID: 7664683
[TBL] [Abstract][Full Text] [Related]
30. Biological and functional characteristics of a novel low-molecular weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, in vitro and in vivo.
Nakamura T; Tanimoto H; Mizuno Y; Tsubamoto Y; Noda H
Diabetes Obes Metab; 2012 Jun; 14(6):511-7. PubMed ID: 22192426
[TBL] [Abstract][Full Text] [Related]
31. Degradation, cyclic adenosine monophosphate production, insulin secretion, and glycemic effects of two novel N-terminal Ala2-substituted analogs of glucose-dependent insulinotropic polypeptide with preserved biological activity in vivo.
Gault VA; O'Harte FP; Harriott P; Flatt PR
Metabolism; 2003 Jun; 52(6):679-87. PubMed ID: 12800091
[TBL] [Abstract][Full Text] [Related]
32. NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.
O'Harte FP; Mooney MH; Flatt PR
Diabetes; 1999 Apr; 48(4):758-65. PubMed ID: 10102692
[TBL] [Abstract][Full Text] [Related]
33. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
34. Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen MB; Christensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
J Clin Endocrinol Metab; 2014 Jul; 99(7):2457-66. PubMed ID: 24712563
[TBL] [Abstract][Full Text] [Related]
35. GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment.
Gabe MBN; Skov-Jeppesen K; Gasbjerg LS; Schiellerup SP; Martinussen C; Gadgaard S; Boer GA; Oeke J; Torz LJ; Veedfald S; Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ; Hartmann B; Rosenkilde MM
Pharmacol Res; 2022 Feb; 176():106058. PubMed ID: 34995796
[TBL] [Abstract][Full Text] [Related]
36. Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptide.
Kerr BD; Flatt AJ; Flatt PR; Gault VA
Biochem Biophys Res Commun; 2011 Jan; 404(3):870-6. PubMed ID: 21184739
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of GIP and the contribution of GIP to the glucose-lowering properties of DPP-4 inhibitors.
Deacon CF
Peptides; 2020 Mar; 125():170196. PubMed ID: 31706956
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the metabolic effects of GIP receptor antagonism and PYY(3-36) receptor activation in high fat fed mice.
Irwin N; Hunter K; Flatt PR
Peptides; 2007 Nov; 28(11):2192-8. PubMed ID: 17884253
[TBL] [Abstract][Full Text] [Related]
39. Chronic desensitization of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats.
Tseng CC; Boylan MO; Jarboe LA; Usdin TB; Wolfe MM
Am J Physiol; 1996 Apr; 270(4 Pt 1):E661-6. PubMed ID: 8928774
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of glucose-induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide), bovine GIP, and bovine GIP(1-39).
Sandberg E; Ahrén B; Tendler D; Carlquist M; Efendić S
Acta Physiol Scand; 1986 Jul; 127(3):323-6. PubMed ID: 3529825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
